These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study. Hoteit M; Dagher M; Tzenios N; Al Kaaki N; Rkein G; Chahine AR; Sacre Y; Hotayt S; Matar R; Hallal M; Maitar M; Hotayt B Healthcare (Basel); 2024 Mar; 12(5):. PubMed ID: 38470703 [TBL] [Abstract][Full Text] [Related]
4. "Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD". Hanna DJ; Jamieson ST; Lee CS; Pluskota CA; Bressler NJ; Benotti PN; Khurana S; Rolston DDK; Still CD Obes Sci Pract; 2021 Oct; 7(5):629-645. PubMed ID: 34631140 [TBL] [Abstract][Full Text] [Related]
5. Treatment of liver cirrhosis in the era of steatotic liver disease. Shimizu M Hepatol Res; 2024 May; ():. PubMed ID: 38806278 [No Abstract] [Full Text] [Related]
6. Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis. Gallo P; Flagiello V; Falcomatà A; Di Pasquale G; D'Avanzo G; Terracciani F; Picardi A; Vespasiani-Gentilucci U J Clin Transl Hepatol; 2024 Mar; 12(3):278-286. PubMed ID: 38426198 [TBL] [Abstract][Full Text] [Related]
7. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Zambon Azevedo V; Silaghi CA; Maurel T; Silaghi H; Ratziu V; Pais R Front Nutr; 2021; 8():774030. PubMed ID: 35111794 [TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation. Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838 [TBL] [Abstract][Full Text] [Related]
11. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512 [TBL] [Abstract][Full Text] [Related]
12. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Rinella ME; Lazarus JV; Ratziu V; Francque SM; Sanyal AJ; Kanwal F; Romero D; Abdelmalek MF; Anstee QM; Arab JP; Arrese M; Bataller R; Beuers U; Boursier J; Bugianesi E; Byrne CD; Castro Narro GE; Chowdhury A; Cortez-Pinto H; Cryer DR; Cusi K; El-Kassas M; Klein S; Eskridge W; Fan J; Gawrieh S; Guy CD; Harrison SA; Kim SU; Koot BG; Korenjak M; Kowdley KV; Lacaille F; Loomba R; Mitchell-Thain R; Morgan TR; Powell EE; Roden M; Romero-Gómez M; Silva M; Singh SP; Sookoian SC; Spearman CW; Tiniakos D; Valenti L; Vos MB; Wong VW; Xanthakos S; Yilmaz Y; Younossi Z; Hobbs A; Villota-Rivas M; Newsome PN; J Hepatol; 2023 Dec; 79(6):1542-1556. PubMed ID: 37364790 [TBL] [Abstract][Full Text] [Related]
13. Sarcopenic obesity is associated with frailty among community-dwelling older adults: findings from the WCHAT study. Yang M; Hu M; Zhang Y; Jia S; Sun X; Zhao W; Ge M; Dong B BMC Geriatr; 2022 Nov; 22(1):863. PubMed ID: 36384475 [TBL] [Abstract][Full Text] [Related]